VIATRIS INC. Increase (Decrease) in Operating Capital
VIATRIS INC. (VTRS) reported Increase (Decrease) in Operating Capital of -$77.00 million for the 9-month period ending 2020-09-27, per its 10-Q filed 2020-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2020-11-10
- VIATRIS INC. increase (decrease) in operating capital for the quarter ending 2020-09-27 was -$72.10M.
- VIATRIS INC. increase (decrease) in operating capital for the quarter ending 2020-06-28 was -$4.90M.
- VIATRIS INC. increase (decrease) in operating capital for the quarter ending 2020-03-29 was $0.00.
| Period end | Increase (Decrease) in Operating Capital 1 month | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 4 month | Increase (Decrease) in Operating Capital 6 month | Increase (Decrease) in Operating Capital 7 month | Increase (Decrease) in Operating Capital 9 month | Increase (Decrease) in Operating Capital 11 month |
|---|---|---|---|---|---|---|---|
| 2020-09-27 | -$72.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$77.00M derived: sum of 2 quarters · filed 2020-11-10 | -$77.00M 10-Q · filed 2020-11-10 | ||||
| 2020-06-28 | -$4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$4.90M 10-Q · filed 2020-08-12 | |||||
| 2020-03-29 | $0.00 10-Q · filed 2020-05-12 | ||||||
| 2019-12-31 | $0.00 10-K · filed 2020-05-07 | ||||||
| 2019-09-29 | $0.00 10-Q · filed 2020-11-10 | ||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-12 | ||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |